From the Department of Radiology (J.D.L., C.W.B., A.W.B., M.P.C., F.K.C., K.L.C., R.S., B.B.T., L.F.A.) and Department of Laboratory Medicine and Pathology (J.T.L.), Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL 32224.
Radiographics. 2022 Jul-Aug;42(4):1043-1061. doi: 10.1148/rg.210156. Epub 2022 Jun 10.
Focal nodular hyperplasia (FNH) is a benign lesion occurring in a background of normal liver. FNH is seen most commonly in young women and can often be accurately diagnosed at imaging, including CT, MRI, or contrast-enhanced US. In the normal liver, FNH frequently must be differentiated from hepatocellular adenoma, which although benign, is managed differently because of the risks of hemorrhage and malignant transformation. When lesions that are histologically identical to FNH occur in a background of abnormal liver, they are termed FNH-like lesions. These lesions can be a source of diagnostic confusion and must be differentiated from malignancies. Radiologists' familiarity with the imaging appearance of FNH-like lesions and knowledge of the conditions that predispose a patient to their formation are critical to minimizing the risks of unnecessary intervention for these lesions, which are rarely symptomatic and carry no risk for malignant transformation. FNH is thought to form secondary to an underlying vascular disturbance, a theory supported by the predilection for formation of FNH-like lesions in patients with a variety of hepatic vascular abnormalities. These include abnormalities of hepatic outflow such as Budd-Chiari syndrome, abnormalities of hepatic inflow such as congenital absence of the portal vein, and hepatic microvascular disturbances, such as those that occur after exposure to certain chemotherapeutic agents. Familiarity with the imaging appearances of these varied conditions and knowledge of their association with formation of FNH-like lesions allow radiologists to identify with confidence these benign lesions that require no intervention. RSNA, 2022.
局灶性结节性增生 (FNH) 是一种发生在正常肝脏背景下的良性病变。FNH 最常见于年轻女性,在影像学检查(包括 CT、MRI 或增强超声)中通常可以准确诊断。在正常肝脏中,FNH 通常必须与肝细胞腺瘤相鉴别,虽然肝细胞腺瘤是良性的,但由于出血和恶性转化的风险,其管理方式不同。当在异常肝脏背景下出现组织学上与 FNH 相同的病变时,它们被称为 FNH 样病变。这些病变可能会导致诊断混淆,必须与恶性肿瘤相鉴别。放射科医生对 FNH 样病变的影像学表现的熟悉程度以及对导致这些病变形成的患者情况的了解,对于最大限度地降低对这些病变进行不必要干预的风险至关重要,因为这些病变很少有症状,且不会发生恶性转化。FNH 被认为是继发于潜在的血管紊乱,这一理论得到了在各种肝血管异常患者中形成 FNH 样病变的倾向的支持。这些异常包括肝流出道异常,如 Budd-Chiari 综合征;肝流入道异常,如门静脉先天性缺失;以及肝微血管异常,如在接触某些化疗药物后发生的异常。熟悉这些不同情况的影像学表现以及它们与 FNH 样病变形成的关联,使放射科医生能够有信心地识别出这些需要干预的良性病变。RSNA,2022 年。